We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$221M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$206M
3
TMO icon
Thermo Fisher Scientific
TMO
+$192M
4
NVDA icon
NVIDIA
NVDA
+$183M
5
AAPL icon
Apple
AAPL
+$183M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VECO icon
1451
Veeco
VECO
$2.99B
$648K ﹤0.01%
25,252
-72,247
-74% -$1.59M
HQH
1452
abrdn Healthcare Investors
HQH
$1.25B
$643K ﹤0.01%
37,717
– –
BASE
1453
DELISTED
Couchbase
BASE
$643K ﹤0.01%
+40,623
New +$664K
POWI icon
1454
Power Integrations
POWI
$3.48B
$642K ﹤0.01%
+6,782
New +$566K
CCS icon
1455
Century Communities
CCS
$2.03B
$642K ﹤0.01%
8,377
+3,076
+58% +$206K
FXG icon
1456
First Trust Consumer Staples AlphaDEX Fund
FXG
$232M
$634K ﹤0.01%
13,962
-1,066
-7% -$66.7K
EGRX
1457
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$629K ﹤0.01%
32,376
+3,667
+13% +$87K
REVG
1458
DELISTED
REV Group
REVG
$626K ﹤0.01%
47,174
+26,062
+123% +$298K
DIVO icon
1459
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.49B
$624K ﹤0.01%
17,341
+11,175
+181% +$397K
BRBR icon
1460
BellRing Brands
BRBR
$1.5B
$622K ﹤0.01%
+16,998
New +$610K
TWI icon
1461
Titan International
TWI
$512M
$622K ﹤0.01%
54,172
-126,084
-70% -$1.34M
ZYME icon
1462
Zymeworks
ZYME
$1.71B
$620K ﹤0.01%
71,740
-99,574
-58% -$892K
AGNT
1463
AGNT Inc
AGNT
$687M
$615K ﹤0.01%
+30,343
New +$454K
IGD
1464
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$507M
$614K ﹤0.01%
119,542
– –
KELYA icon
1465
Kelly Services Class A
KELYA
$540M
$613K ﹤0.01%
+34,829
New +$603K
LMAT icon
1466
LeMaitre Vascular
LMAT
$2.25B
$609K ﹤0.01%
+9,058
New +$553K
AMWD
1467
DELISTED
American Woodmark
AMWD
$607K ﹤0.01%
7,952
-13,469
-63% -$782K
CFO icon
1468
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$417M
$605K ﹤0.01%
+10,500
New +$646K
RWR icon
1469
State Street SPDR Dow Jones REIT ETF
RWR
$1.91B
$603K ﹤0.01%
9,889
-1,460
-13% -$129K
PPH icon
1470
VanEck Pharmaceutical ETF
PPH
$969M
$600K ﹤0.01%
7,614
+2,345
+45% +$184K
PPLT
1471
abrdn Physical Platinum Shares ETF
PPLT
$1.85B
$600K ﹤0.01%
+71,680
New +$680K
BNDW icon
1472
Vanguard Total World Bond ETF
BNDW
$1.89B
$597K ﹤0.01%
7,552
+7,511
+18,320% +$515K
ACAD icon
1473
Acadia Pharmaceuticals
ACAD
$4.4B
$595K ﹤0.01%
+24,839
New +$552K
SWTX
1474
DELISTED
SpringWorks Therapeutics
SWTX
$591K ﹤0.01%
+22,549
New +$593K
BEKE icon
1475
KE Holdings
BEKE
$17.3B
$588K ﹤0.01%
39,620
-176,758
-82% -$2.89M
57 58
59
60 61

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.